Tuesday, 8 July 2014

PubMed Update May/June 2014


25 papers in two months. Anyone want to help with this?

Sabzghabaee AM, Eizadi-Mood N, Yaraghi A, Zandifar S.
Arch Med Sci. 2014 May 12;10(2):309-14. doi: 10.5114/aoms.2014.42584. Epub 2014 May 13.
PMID: 24904666 [PubMed] Free PMC Article
Comments: More data to support the utility of intranasal naloxone for overdose reversal. There are, however, some odd findings that suggest caution in interpreting the paper. The authors used 0.4mg of naloxone for IV or IN administration, whereas most efforts utilize 2mg for IN administration given the lower bioavailability. Moreover, they had a higher level of consciousness in the IN group, which seems odd.

Rambod M, Elhanafi S, Mukherjee D.
Ann Noninvasive Electrocardiol. 2014 Jun 5. doi: 10.1111/anec.12171. [Epub ahead of print]
PMID: 24903622 [PubMed - as supplied by publisher]
Comments: There are cases in which opioids can result in unstable heart rhythms. Usually this is related to high dose methadone, prolongation of the QT interval and torsades de pointes. In this case, heroin plus alcohol may have resulted in electrical conduction similar to “Brugada syndrome” which, in the interest of having an image in this blog post, I’ve posted an image of here. This type of electrical conduction is usually genetic and can result in sudden death through lethal arrhythmias.


Clark AK, Wilder CM, Winstanley EL.
J Addict Med. 2014 May-Jun;8(3):153-63. doi: 10.1097/ADM.0000000000000034.
PMID: 24874759 [PubMed - in process]
Comments: An impressive review of existing data for naloxone programs. Big kudos to the authors.

Iwersen-Bergmann S, Jungen H, Andresen-Streichert H, Müller A, Elakkary S, Püschel K, Heinemann A.
Int J Legal Med. 2014 May 25. [Epub ahead of print]
PMID: 24859230 [PubMed - as supplied by publisher]
Comments: Interesting analysis of methadone-related deaths among methadone maintenance patients suggesting that, while overdose deaths are not common, many may have been related to IV use of methadone.

Liu X, Wang G, Pu H, Jing H.
Brain Res. 2014 Jul 14;1572:40-9. doi: 10.1016/j.brainres.2014.05.016. Epub 2014 May 20.
PMID: 24854119 [PubMed - in process]
Comments: Intriguing analysis of rat brains suggesting a key role of calcium in neurotoxicity related to heroin use. Do medications like verapamil, generally used to manage hypertension, have a role in preventing neurologic damage from opioids and perhaps even reducing overdose risk?

Wang KH, Fiellin DA, Becker WC.
Am J Drug Alcohol Abuse. 2014 Jul;40(4):292-303. doi: 10.3109/00952990.2014.907301. Epub 2014 May 22.
PMID: 24853143 [PubMed - in process]
Comments: Around a fifth of people using prescription opioids “non-medically” get them directly from a physician.


Koller AC, Salcido DD, Menegazzi JJ.
Prehosp Emerg Care. 2014 May 15. [Epub ahead of print]
PMID: 24831102 [PubMed - as supplied by publisher]
Comments: A survey mostly of physicians and paramedics showing that healthcare providers manage cardiac arrest differently if it is from drug overdose versus a different etiology. This sounds quite reasonable, actually, since etiology-specific management is encouraged particularly for cardiac arrests due to “pulseless electrical activity” (that is, while we shock most arrhythmias during cardiac arrest, if there is no arrhythmia to shock we generally don’t shock and do a bunch of other things – one of those things is to guess what may be causing the cardiac arrest and administering medications to try to counteract that problem).

Koller AC, Salcido DD, Callaway CW, Menegazzi JJ.
Resuscitation. 2014 Jun 26. pii: S0300-9572(14)00581-4. doi: 10.1016/j.resuscitation.2014.05.036. [Epub ahead of print]
PMID: 24973558 [PubMed - as supplied by publisher]
Comments: Overdose-related cardiac arrests are more likely to survive. They are also more likely to be younger and to receive different immediate care. These findings are consistent with the above opinion survey.

Green TC, Ray M, Bowman SE, McKenzie M, Rich JD.
Subst Abus. 2014;35(2):129-32. doi: 10.1080/08897077.2013.825691.
PMID: 24821348 [PubMed - in process]
Comments: There have been rare cases of naloxone self-administration in the setting of lay naloxone programs. This obviously should not be the goal, as most people in need of naloxone will be unconscious by the time they need it.

Farsi D, Mirafzal A, Hassanian-Moghaddam H, Azizi Z, Jamshidnejad N, Zehtabchi S.
Cardiovasc Toxicol. 2014 May 9. [Epub ahead of print]
PMID: 24811951 [PubMed - as supplied by publisher]
Comments: Prolonged QT interval in methadone overdose patients predicts respiratory arrest, need for intubation, and death.

Zlotorzynska M, Milloy MJ, Richardson L, Nguyen P, Montaner JS, Wood E, Kerr T.
Int J Drug Policy. 2014 Apr 4. pii: S0955-3959(14)00075-9. doi: 10.1016/j.drugpo.2014.03.014. [Epub ahead of print]
PMID: 24795288 [PubMed - as supplied by publisher]
Comments: People overdose when they get their monthly assistance checks. There are some programs that provide “money management” services, doling out participants monthly incomes over time – these may help to reduce binge drug use and related overdose events.

[No authors listed]
Med Lett Drugs Ther. 2014 Mar 17;56(1438):21-2. No abstract available.
PMID: 24662159 [PubMed - indexed for MEDLINE]
Comments: Unable to access.

Schuman-Olivier Z, Connery H, Griffin ML, Wyatt SA, Wartenberg AA, Borodovsky J, Renner JA Jr, Weiss RD.
Am J Addict. 2013 Nov-Dec;22(6):574-80. doi: 10.1111/j.1521-0391.2013.12024.x. Epub 2013 Apr 11.
PMID: 24131165 [PubMed - indexed for MEDLINE]
Comments: About 40% of providers think buprenorphine/naloxone diversion is a problem. I’m unable to access the article, but the abstract says providers who have experience using the medication think diversion is a result of limited access to the medication. I concur with that opinion … but I am also one of those providers.

Heilbronn C, Lloyd B, McElwee P, Eade A, Lubman DI.
Drug Alcohol Rev. 2013 Jul;32(4):405-11. doi: 10.1111/dar.12028. Epub 2013 Jan 27.
PMID: 23350582 [PubMed - indexed for MEDLINE]
Comments: Quetiapine is a sedating anti-psychotic that is often favored by those with opioid use disorders.

Stöver HJ, Schäffer D.
Harm Reduct J. 2014 Jun 27;11(1):18. [Epub ahead of print]
PMID: 24973031 [PubMed - as supplied by publisher] Free Article
Comments: Efforts to transition users from injection to smoking heroin in Europe seem to be growing in popularity with increasing evidence of effectiveness. Of note, one major limitation is the pH of different formulations of heroin. Heroin in the United States, for example, may be too acidic for most users to transition to smoking (which generally requires a “basic” acid/base balance to allow the drug to be vaporized without burning).

Unick G, Rosenblum D, Mars S, Ciccarone D.
Addiction. 2014 Jun 17. doi: 10.1111/add.12664. [Epub ahead of print]
PMID: 24938727 [PubMed - as supplied by publisher]
Comments: Purity of heroin has some association with overdose and there seems to be a difference in the geographic source of the heroin in terms of overdose risk.

Hammett TM, Phan S, Gaggin J, Case P, Zaller N, Lutnick A, Kral AH, Fedorova EV, Heimer R, Small W, Pollini R, Beletsky L, Latkin C, Des Jarlais DC.
BMC Health Serv Res. 2014 Jun 17;14:261. doi: 10.1186/1472-6963-14-261.
PMID: 24938376 [PubMed - in process] Free PMC Article
Comments: Notwithstanding many efforts to expand the role of pharmacists in community health, the legal and social stigma surrounding injection drug use seriously limits the implementation and impact of these policy and programmatic efforts. I can only imagine this is going to get worse before it gets better, as pharmacists are increasingly being held to higher standards of evaluating the appropriateness of prescriptions for patients.

Zedler B, Xie L, Wang L, Joyce A, Vick C, Kariburyo F, Rajan P, Baser O, Murrelle L.
Pain Med. 2014 Jun 14. doi: 10.1111/pme.12480. [Epub ahead of print]
PMID: 24931395 [PubMed - as supplied by publisher]
Comments: Dose, dependence, prior overdose, liver disease and use of long-acting opioids were the primary predictors of overdose.

Hadland SE, DeBeck K, Kerr T, Nguyen P, Simo A, Montaner JS, Wood E.
J Adolesc Health. 2014 Jun 9. pii: S1054-139X(14)00191-8. doi: 10.1016/j.jadohealth.2014.04.013. [Epub ahead of print]
PMID: 24925493 [PubMed - as supplied by publisher]
Comments: INSITE serves the population of extremely high-risk, young injectors.

Davis CS, Ruiz S, Glynn P, Picariello G, Walley AY.
Am J Public Health. 2014 Jun 12:e1-e3. [Epub ahead of print]
PMID: 24922133 [PubMed - as supplied by publisher]
Comments: This policy review is, I believe, the first publication in the scientific literature on the relatively new phenomenon of providing non-ACLS trained first responders with naloxone.

Bileviciute-Ljungar I, Häglund V, Carlsson J, von Heijne A.
J Rehabil Med. 2014 Jun 4. doi: 10.2340/16501977-1820. [Epub ahead of print]
PMID: 24909124 [PubMed - as supplied by publisher]
Comments: Methadone overdose has resulted in a delayed leukoencephalopathy – basically a sickness in the white matter of the brain. This can result in substantial and lifelong dysfunction. There is some improvement, but it can require a fair amount of medication and still have at least moderate neurologic dysfunction that may never resolve. If you know someone who had a methadone overdose and they don’t seem to be getting better, this should be considered.

Mettner J.
Minn Med. 2014 Apr;97(4):10-1. No abstract available.
PMID: 24868924 [PubMed - indexed for MEDLINE]
Comments: Can’t access.

Jacobson J.
Am J Nurs. 2014 May;114(5):22-3. doi: 10.1097/01.NAJ.0000446774.91899.b5. No abstract available.
PMID: 24759473 [PubMed - indexed for MEDLINE]
Comments: A news article on naloxone.

Gwira Baumblatt JA, Wiedeman C, Dunn JR, Schaffner W, Paulozzi LJ, Jones TF.
JAMA Intern Med. 2014 May;174(5):796-801.
PMID: 24589873 [PubMed - indexed for MEDLINE]
Comments: Opioid overdose deaths in Tennessee had, compared to national data, an abundance of what is referred to as “doctor shopping.” Among patients prescribed opioids, 7.6% had >4 prescribers and 2.5% >4 pharmacies. While one should be cautious about overinterpreting the number of prescribers (as perhaps they were urgent care or other affiliated providers filling in for the primary prescriber), most analyses suggest that around 1% of patients fit the pharmacy criteria. These patients were the most likely to die of opioid overdose.

Favrod-Coune T, Baroudi M, Casillas A, Rieder JP, Gétaz L, Barro J, Gaspoz JM, Broers B, Wolff H.
Swiss Med Wkly. 2013 Nov 1;143:w13898. doi: 10.4414/smw.2013.13898.
PMID: 24186493 [PubMed - indexed for MEDLINE] Free Article
Comments: In-prison methadone maintenance.

Nielsen MK, Johansen SS, Linnet K.
Drug Alcohol Depend. 2013 Dec 1;133(2):447-51. doi: 10.1016/j.drugalcdep.2013.07.001. Epub 2013 Jul 25.
PMID: 23891033 [PubMed - indexed for MEDLINE]
Comments: Investigators were unable to establish a methodology that would allow them to distinguish between those who had reduced tolerance and those who did not, among methadone overdose deaths.


Tuesday, 27 May 2014

PubMed Update March/April 2014

Better late than never, right? 24 papers over two months.


Doe-Simkins M, Quinn E, Xuan Z, Sorensen-Alawad A, Hackman H, Ozonoff A, Walley AY.
BMC Public Health. 2014 Apr 1;14(1):297. [Epub ahead of print]
Comments: Sometimes naloxone is used by bystanders who have not been formally educated (or “trained”) in administering naloxone. This innovative analysis suggests that the untrained witness does a good job in lay naloxone administration.

Kuehn BM.
JAMA. 2014 Apr 23-30;311(16):1600. doi: 10.1001/jama.2014.4483. No abstract available.
Comments: The naloxone auto-injector – Evzio – has been approved and is expected to be available this summer.

3) Research gaps on methadone harms and comparative harms: findings from a review of the evidence for an american pain society and college on problems of drug dependence clinical practice guideline.
Weimer MB, Chou R.
J Pain. 2014 Apr;15(4):366-76. doi: 10.1016/j.jpain.2014.01.496.
Comments: Basic summary is that it’s not entirely clear why there was such a surge in methadone-related deaths in the early part of the 2000s. It’s important to remember that the surge came after a surge in oxycontin-related deaths, when many payers shifted their preferred agent from oxycontin to methadone. Mortality data seems to follow the trend of the most prescribed agent.

Moore C, Lloyd G, Oretti R, Russell I, Snooks H.
BMJ Open. 2014 Mar 20;4(3):e004712. doi: 10.1136/bmjopen-2013-004712.
Comments: Outstanding, innovative design to reach those at very high risk of future overdose events. I anxiously await results.


5) Intranasal naloxone for treatment of opioid overdose.
[No authors listed]
Med Lett Drugs Ther. 2014 Mar 17;56(1438):21-4. No abstract available.
Comments: Can’t access.

Facey C, Brooks D.
BMJ Support Palliat Care. 2014 Mar;4 Suppl 1:A103. doi: 10.1136/bmjspcare-2014-000654.297.
Comments: All I see is an abstract here that suggests naloxone is being over-administered to patients on long-acting opioids in the inpatient setting. This is hard to assess without more details, including the context of the facility, but I am somewhat skeptical of the authors stark conclusions. The authors state that the only reason to administer naloxone is respiratory depression. There are flaws with this – providers often don’t document respiratory rate or use default parameters and don’t actually measure the rate; oxygenation is often a far better parameter; and there are other reasons to administer naloxone in a monitored setting, such as hypotension which is often caused by opioids and may be somewhat improved with naloxone.

Poloméni P, Schwan R.
Int J Gen Med. 2014 Mar 3;7:143-8. doi: 10.2147/IJGM.S53170. eCollection 2014.
Comments: A history and update on opioid use disorder management in France, including summary of the remarkable impact of buprenorphine on overdose mortality in that country.

Chou R, Weimer MB, Dana T.
J Pain. 2014 Apr;15(4):338-65. doi: 10.1016/j.jpain.2014.01.495.
Comments: Methadone has a long history of potential issues with the QT phase of the cardiac cycle (we’ve discussed this before on this blog so I won’t include a nifty cardiac cycle picture again here). One question with the surge in methadone deaths was if it was related to the lengthening of the QT interval. The basic summary is that there’s no data to support that at this time.

Chou R, Cruciani RA, Fiellin DA, Compton P, Farrar JT, Haigney MC, Inturrisi C, Knight JR, Otis-Green S, Marcus SM, Mehta D, Meyer MC, Portenoy R, Savage S, Strain E, Walsh S, Zeltzer L.
J Pain. 2014 Apr;15(4):321-37. doi: 10.1016/j.jpain.2014.01.494.
Comments: No recommendations were based on high-quality data.

10) Methadone Overdose and Withdrawal in a Tetraplegic Patient: A Case Report.
Connelly P, Wu H.
PM R. 2014 Mar 2. pii: S1934-1482(14)00098-7. doi: 10.1016/j.pmrj.2014.02.012. [Epub ahead of print] No abstract available.
Comments: Methadone is metabolized by enzymes in the liver that are also affected by other common drugs. In this case ciprofloxacin and phenytoin messed up the metabolism and caused overdose, then withdrawal. This is also a reminder that overdose isn’t always evidence of a substance use disorder – it is a risk of ‘risky medications’ not necessarily ‘risky patients.’

Baumblatt JA, Wiedeman C, Dunn JR, Schaffner W, Paulozzi LJ, Jones TF.
JAMA Intern Med. 2014 Mar 3. doi: 10.1001/jamainternmed.2013.12711. [Epub ahead of print]
Comments: Risk factors for death were high dose opioid prescription and using multiple providers – 55% of deaths had one of these risk factors. What’s interesting, however, is the other 45%, who did not have any of these risk factors.

Eggertson L.
CMAJ. 2014 Jan 7;186(1):17. doi: 10.1503/cmaj.109-4663. Epub 2013 Nov 25. No abstract available.
Comments: A news article in the journal regarding naloxone programs.

Nuckols TK, Anderson L, Popescu I, Diamant AL, Doyle B, Di Capua P, Chou R.
Ann Intern Med. 2014 Jan 7;160(1):38-47. doi: 10.7326/0003-4819-160-1-201401070-00732. Review.
Comments: There are lots of guidelines for reducing risk with opioid prescribing but no data.

Jones CM.
Drug Alcohol Depend. 2013 Sep 1;132(1-2):95-100. doi: 10.1016/j.drugalcdep.2013.01.007. Epub 2013 Feb 12.
Comments: Opioid use precedes heroin use, heroin use is going up.

Jozaghi E.
Int J Qual Stud Health Well-being. 2014 Mar 13;9:23698. doi: 10.3402/qhw.v9.23698. eCollection 2014.
Comments: Personal level experience in heroin treatment programs.

Naso-Kaspar CK, Herndon GW, Wyman JF, Felo JA, Lavins ES, Gilson TP.
J Anal Toxicol. 2013 Oct;37(8):507-11. doi: 10.1093/jat/bkt061. Epub 2013 Jul 18.
Comments: Analysis of opiate levels from femoral and cerebral sources suggesting opiates linger in the brain – authors suggest this may explain low blood opioid levels in overdose deaths but I’m not sure that’s a reasonable conclusion.

Gjersing L, Bretteville-Jensen AL.
Drug Alcohol Depend. 2013 Nov 1;133(1):121-6. doi:
Comments: Yes.

Volkow ND, Frieden TR, Hyde PS, Cha SS.
N Engl J Med. 2014 Apr 23. [Epub ahead of print]
Comments: A discussion of methadone, buprenorphine and naltrexone as responses to the opioid overdose epidemic.

Even KM, Armsby CC, Bateman ST.
Clin Toxicol (Phila). 2014 Apr 17. [Epub ahead of print]
Comments: An increasing proportion of pediatric poisonings involve opioids.

Wikner BN, Ohman I, Seldén T, Druid H, Brandt L, Kieler H.
Drug Alcohol Rev. 2014 Apr 16. doi: 10.1111/dar.12143. [Epub ahead of print]
Comments: Rarely does methadone or buprenorphine prescribed for maintenance result in death. I can’t access the full article so cannot assess quality.

Gambaro V, Argo A, Cippitelli M, Dell'acqua L, Farè F, Froldi R, Guerrini K, Roda G, Rusconi C, Procaccianti P.
J Anal Toxicol. 2014 Jun;38(5):289-94. doi: 10.1093/jat/bku016. Epub 2014 Apr 11.
Comments: Codeine may accumulate in brain tissue more than morphine (heroin’s major metabolites are codeine, morphine, and 6-monoacetylmorphine).

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2013 Nov 14.
Comments: They are similar.

Bonnet U, Stratmann U, Isbruch K.
Dtsch Med Wochenschr. 2014 Feb;139(8):375-7. doi: 10.1055/s-0033-1360065. Epub 2014 Feb 11. German.
Comments: An odd case report.

Newman RG.
J Addict Med. 2014 Jan-Feb;8(1):73. doi: 10.1097/ADM.0000000000000014. No abstract available.

Comments: A letter responding to “Methadone-related overdose deaths in rural Virginia: 1997 to 2003” – I can’t access.

Monday, 3 March 2014

PubMed Update February 2014

8 papers today, essentially about naloxone and heroin.

Maurer U, Kager C, Fellinger C, Loader D, Pollesböck A, Spitzer B, Jarisch R.
Subst Abuse Treat Prev Policy. 2014 Feb 27;9(1):12. [Epub ahead of print]

Comment: Seeking alternative explanations for “overdose”, the authors explored histamine levels in heroin using individuals. They found that heroin users had greater spikes in histamine levels when exposed to IV heroin compared to oral morphine. They hypothesized that this may explain why so many cases of overdose have a sublethal concentration of opioids, but this seems an overreach based on their data.


Kan M, Gall JA, Latypov A, Gray R, Alisheva D, Rakhmatova K, Sadieva AS.
Int J Drug Policy. 2014 Jan 23. pii: S0955-3959(14)00008-5. doi: 10.1016/j.drugpo.2014.01.005. [Epub ahead of print]

Comment: 47 to 81% of naloxone kits given out in Kyrgyzstan and Tajikistan were used to reverse an overdose – remarkable numbers, from 3 to 5 times higher than seen in western states.


Hansen A.
BMJ. 2014 Feb 20;348:g1686. doi: 10.1136/bmj.g1686. No abstract available.

Comment: Naloxone in Norway.


Seo S, Kwon YS, Yu K, Kim SW, Kwon OY, Kang KH, Kwon K.
Mol Med Rep. 2014 Apr;9(4):1395-9. doi: 10.3892/mmr.2014.1935. Epub 2014 Feb 7.

Comment: I can only see the abstract for this one and the science is outside of my realm – I’m unable to identify anything of apparent clinical relevance.


Bailey AM, Wermeling DP.
Ann Pharmacother. 2014 Feb 12. [Epub ahead of print]

Comment: Very helpful and relevant summary of some pharmacists experience with dispensing naloxone.


Aulet RM, Flis D, Sillman J.
Case Rep Otolaryngol. 2014;2014:962759. doi: 10.1155/2014/962759. Epub 2014 Jan 6.

Comment: Another case of opioid overdose-related sensorineural hearing loss, which means hearing loss from the cochlea (inner ear). The authors kindly run through some theories, including hypotension (e.g. reduced blood flow to the inner ear), overstimulation of kappa opioid receptors present in the cochlea, or adulteration with an ototoxic substance such as quinine.


Sarasa-Renedo A, Espelt A, Folch C, Vecino C, Majó X, Castellano Y, Casabona J, Brugal MT; Redan Study Group.
Gac Sanit. 2014 Jan 10. pii: S0213-9111(13)00227-6. doi: 10.1016/j.gaceta.2013.10.012. [Epub ahead of print]

Comment: Substance use disorder treatment programs are increasingly engaging in overdose prevention efforts – a badly needed development.


Dietze P.
Addiction. 2013 Jul;108(7):1277-8.

Comment: Interesting remarks by the author, suggesting that rather than advertising the high potency heroin, simply noting a spike in deaths and advertising overdose prevention/response strategies may be safer and more relevant to the target population.

Saturday, 15 February 2014

PubMed Update January 2014

10 papers this month, half of which relate to the United Kingdom. We continue to move forward.

Cropsey KL, Martin S, Clark CB, McCullumsmith CB, Lane PS, Hardy S, Hendricks PS, Redmond N.
J Opioid Manag. 2013 Nov-Dec;9(6):393-400.
Comments: Valuable survey of persons in the corrections system, under community supervision. Nearly half had used opioids and 40% of those had experienced an opioid overdose. Those who had overdosed were more likely to be white, female, and have higher educational attainment; they were also much more likely to have witnessed overdose, have seen someone die of overdose, and want training in overdose prevention and management.

Chaparro LE, Furlan AD, Deshpande A, Mailis-Gagnon A, Atlas S, Turk DC.
Spine (Phila Pa 1976). 2014 Jan 29. [Epub ahead of print]
Comments: A review of studies evaluating short term use of opioids for chronic lower back pain. The studies evaluated all have major shortcomings so we’re left with little new information.

Adrish M, Duncalf R, Diaz-Fuentes G, Venkatram S.
Am J Case Rep. 2014 Jan 15;15:22-6
Comments: Being “down” with an overdose for a prolonged period can lead to complications such as rhabdomyolysis and nerve compression. This patient developed compartment syndrome, which is to say high pressure within the fascial compartment of the buttocks, requiring surgical intervention to spare her extremity.


Darke S, Farrell M.
Addiction. 2014 Jan 24. doi: 10.1111/add.12456. [Epub ahead of print]
Comments: If anyone is reading this, this article should lead to some discussion. It is hard to argue with the recent United States experience with broad availability of opioid analgesics and resultant four-fold increase in opioid overdose death rates. When OxyContin was the choice longacting agent, that was the offender, then providers shifted to prescribing methadone and that became the principal offender, then the offender switched to whichever longacting opioid became the dominant prescribed opioid in a given community. When those communities stop prescribing opioids, heroin tops the charts. While there is room for a lively debate and this paper does not help us solve the current US crisis, the central conclusion that merely making opioids widely available at a known dose and free of adulterants would not reduce overdose mortality on a community or national level seems valid. That said, it is conceivable that such availability reduces mortality among those already dependent on opioids – complicating any assessment.

Matheson C, Pflanz-Sinclair C, Aucott L, Wilson P, Watson R, Malloy S, Dickie E, McAuley A.
BMC Fam Pract. 2014 Jan 15;15(1):12.
Comments: A survey of general practitioners in Scotland demonstrating mixed knowledge and interest in overdose prevention. Many seemed to feel this was a specialist service rather than one that a generalist should provide. Those with more experience with drug use were generally more supportive.

Tait RJ, Lenton S.
Addiction. 2014 Feb;109(2):260-1.
Comments: A commentary on the OOKS and OOAS overdose scales produced in the UK.

Siegler A, Tuazon E, Bradley O'Brien D, Paone D.
Int J Drug Policy. 2013 Nov 8. pii: S0955-3959(13)00178-3. [Epub ahead of print]
Comments: I’ve been anxiously awaiting the papers coming out of New York. They’ve done a great job dedicating resources to tracking and attempting to reduce opioid overdose mortality. Please keep writing!

Bennett T, Holloway K, Bird SM.
Lancet. 2014 Jan 11;383(9912):124-5.
Comments: The title doesn’t really match the text, but this is a very nice brief analysis of non-fatal overdose events in Wales. 47% of opioid injectors had overdosed and 15% had overdosed in the preceding 12 months, with a median 2 overdose events during that period. Data such as these are invaluable in generating event-level estimates of opioid overdose occurrence and outcome.

Handley SA, Flanagan RJ.
Clin Toxicol (Phila). 2014 Jan 7. [Epub ahead of print]
Comments: Nice trend analysis of poisoning deaths in England and Wales demonstrating a fairly stable number of opioid related deaths over that period.

Stavseth LS, Kunøe N, Tanum L.
Tidsskr Nor Laegeforen. 2013 Nov 12;133(21):2231-2. Norwegian.
Comments: This appears to be a letter but that’s all I can tell!